0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Editorial |

Active Surveillance for Prostate Cancer

Ian M. Thompson, MD; Laurence Klotz, MD
JAMA. 2010;304(21):2411-2412. doi:10.1001/jama.2010.1761.
Text Size: A A A
Published online

Extract

Since 1980, the prognosis of prostate cancer has changed markedly as the United States has moved through 3 eras. The first era reflected the experience of the prior century. Because prostate cancer is usually asymptomatic until it is metastatic and rectal examination has a low sensitivity for early cancer detection, most men had advanced and incurable disease at diagnosis. During the second era in the mid-1980s, with the advent of prostate-specific antigen (PSA) testing, at-risk men underwent prostate biopsy, leading to a doubling of incidence rates and a stage shift, with a substantially higher fraction of men with curable disease at diagnosis.1 This increase in numbers of patients suitable for curative therapy (surgery or radiation) facilitated a reduction in complications and morbidity. The increasing proportion of men achieving long-term cure was gratifying. Even though randomized studies of screening have reached discordant conclusions about how screening affects cure, prostate cancer mortality declined 39% in the United States from 1990 to 2006.2

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

First Page Preview

View Large
First page PDF preview

Figures

Tables

References

Letters

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Web of Science® Times Cited: 17

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

Related Multimedia

Author Interview

Articles Related By Topic
Related Collections
PubMed Articles
Jobs
brightcove.createExperiences();